Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 7/20 | 0.41 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6099133 | 0.87 | CHRM2 (0.39) | RORC | |
| SCHEMBL6098038 | 0.87 | TAAR1 (0.38) | RORCFFAR2CYP2C19DGAT2 | |
| SCHEMBL6095467 | 0.83 | RORC (0.46) | RORCCYP2C19HSD17B10KDM4E | |
| SCHEMBL6097247 | 0.82 | CYP2C19 (0.38) | RORCCYP2C19CHRM5 | |
| SCHEMBL6097505 | 0.81 | RORC (0.34) | RORCCYP2C19HSD17B10TSHRKDM4E | |
| SCHEMBL6095436 | 0.81 | CYP2C19 (0.41) | RORCCYP2C19 | |
| SCHEMBL6098125 | 0.81 | FABP6 (0.36) | RORCTSHRKDM4E | |
| SCHEMBL6097882 | 0.81 | RORC (0.34) | RORCCYP2C19HSD17B10TSHRKDM4E | |
| SCHEMBL6098065 | 0.81 | ALDH1A1 (0.47) | HSD11B1CHRM5KDM4E | |
| Hydrochloric Acid SCHEMBL6097193 | 0.81 | CYP2C19 (0.40) | RORCCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101892-B2 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. | 2006-09-05 | — | — | US | disclosed |
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | HTR7, HTR2C, HTR1A | RORC 669/4885FFAR2 133/4885CYP2C19 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.